“…Regardless of gender, younger age was associated with higher functioning and lower symptom severity score, and emotional suffering was generally reported to be more severe than physical symptoms. [86] Of note, results in this study did not demonstrate a relationship between type of treatment and HRQOL outcomes. In a study out of the Southwest Oncology Group in the United States, a comparison of HRQOL in patients treated with either EFRT or CMT found persistent fatigue reported by survivors of each treatment modality, but again without differences according to treatment.…”